COVID-19: Sputnik V developer says its vaccine cheaper than Pfizer, Moderna – Check costs right here | World News

The developer of Sputnik V have claimed that the worth of the Russian coronavirus vaccine Sputnik V will be decrease than the vaccine developed by Pfizer and Moderna.

“Translating pharma lingo: the announced price of Pfizer of USD 19.50 (Rs 1446) and Moderna of USD 25-USD 37 (Rs 1854.07-2744.02) per dose actually means their price of USD 39 (Rs 2892.34) and USD 50-USD 74 (Rs 3708.13-5488.04) per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower,” the official account stated.

It is to be famous that each Pfizer and Moderna are US-based companies.

On August 11, Russia turned the primary nation on this planet  to register the primary COVID-19 vaccine. Sputnik V was developed by the Gamaleya National Research Centre for Epidemiology and Microbiology of the Russian Healthcare Ministry.

Russia had claimed on November 11 that Sputnik V vaccine has been discovered to be 92 per cent efficient at defending people from COVID-19.

On November 17, Moderna introduced that US NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 research of mRNA-1273 has knowledgeable Moderna vaccine has a efficacy of 94.5%.

On November 18, Pfizer officially introduced that closing outcomes from the late-stage trial of its vaccine towards COVID-19 was discovered to be 95 per cent efficient.


NEWS EXPRESS.IN Get all latest & breaking news online news portal providing & updated news 24* 7

Related Articles

Back to top button